Publications in collaboration with researchers from Mayo Clinic (10)

2023

  1. A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

    Nature Medicine, Vol. 29, Núm. 7, pp. 1867-1876

  2. Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD

    Journal of the American Society of Nephrology : JASN, Vol. 34, Núm. 6, pp. 955-968

  3. Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification

    Mayo Clinic Proceedings

  4. Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification

    Kidney International, Vol. 104, Núm. 6, pp. 1092-1102

2022

  1. Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression

    Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 2, pp. 291-303

2021

  1. Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis

    American Journal of Kidney Diseases, Vol. 78, Núm. 3, pp. 340-349.e1

  2. Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy

    Journal of the American Society of Nephrology, Vol. 32, Núm. 2

2017

  1. A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis

    Kidney International Reports, Vol. 2, Núm. 5, pp. 800-810

2012

  1. Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis

    Kidney International Supplements, Vol. 2, Núm. 2, pp. 139-274

2004

  1. Anti-proteinuric effect of losartan: Statistical vs clinical significance (multiple letters) [1]

    Nephrology Dialysis Transplantation